secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silexion Therapeutics Corp (SLXN)
CIK:        0002022416
Form:       8-K
Filed at:   2025-08-01T23:59:59+00:00
Accession:  0001178913-25-002570
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Silexion exercises 152K warrants at $11.57 for ~$1.8M gross; issues new warrants
--------------------------------------------------------------------------------

- Exercises 152,106 existing warrants at $11.57/share; gross proceeds ~$1.8M before fees.
- Issues new warrants for up to 304,212 ordinary shares at $11.32/share; 24-month term from resale registration.
- Closing expected August 1, 2025; shareholder meeting August 12 for authorized share increase.
- H.C. Wainwright receives 7% cash fee, management fee, and warrants as placement agent.
- Company to file resale registration statement within 30 days; 15-day lock-up and 1-year variable rate transaction ban.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2022416/000117891325002570/0001178913-25-002570-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2022416/000117891325002570/zk2533522.htm
  HTML page:      https://secwatch.observer/filing/0001178913-25-002570

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer